AEP
51
-2
PAYX
51
-3
FE
45
-3
OI
37
-5
PX
62
-4
SLG
55
-4
KMX
66
2
FLS
75
3
IFF
54
-5
TRV
55
-3
MCO
78
-2
MMC
62
-5
UNP
42
-7
WY
57
-2
NWS
90
26
UA
48
-3
AA
53
-3
NKE
40
-2
DFS
71
-2
NAVI
50
-5
AEP
51
-2
PAYX
51
-3
FE
45
-3
OI
37
-5
PX
62
-4
SLG
55
-4
KMX
66
2
FLS
75
3
IFF
54
-5
TRV
55
-3
MCO
78
-2
MMC
62
-5
UNP
42
-7
WY
57
-2
NWS
90
26
UA
48
-3
AA
53
-3
NKE
40
-2
DFS
71
-2
NAVI
50
-5
Financhill
Back

Compagnie Financiere Richemont SA Vs. Janux Therapeutics Industry Stock Comparison

Sell
37

CFRUY
Compagnie Financiere Richemont SA

Last Price:
14.53
Seasonality Move:
6.19%
Sell
34

JANX
Janux Therapeutics

Last Price:
66.94
Seasonality Move:
133.13%
Sell
37
Compagnie Financiere Richemont SA (CFRUY) is a Sell

Is Compagnie Financiere Richemont SA a Buy, Sell or Hold?

  • The current Compagnie Financiere Richemont SA [CFRUY] share price is $14.41. The Score for CFRUY is 37, which is 26% below its historic median score of 50, and infers higher risk than normal.
  • CFRUY is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
34
Janux Therapeutics (JANX) is a Sell

Is Janux Therapeutics a Buy, Sell or Hold?

  • The current Janux Therapeutics [JANX] share price is $59.86. The Score for JANX is 34, which is 32% below its historic median score of 50, and infers higher risk than normal.
  • JANX is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

CFRUY Stock Price Chart

What is Compagnie Financiere Richemont SA's stock price today?

  • The Compagnie Financiere Richemont SA share price today is $14.41
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and CFRUY is experiencing buying pressure, which is a positive indicator for future bullish movement.

JANX Stock Price Chart

What is Janux Therapeutics's stock price today?

  • The Janux Therapeutics share price today is $59.86
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and JANX is experiencing selling pressure, which indicates risk of future bearish movement.

CFRUY Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.11 Sell
Relative Strength Index (14 RSI): 59.38 Buy
Chaikin Money Flow: 1451557 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (13.38 - 14.4) Buy
Bollinger Bands (100): (13.91 - 15.45) Sell

JANX Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.63 Sell
Relative Strength Index (14 RSI): 63.62 Buy
Chaikin Money Flow: -6955717 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (47.07 - 55.53) Buy
Bollinger Bands (100): (41.63 - 51.75) Buy

CFRUY Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 13.75 Buy
20-day SMA: 13.72 Buy
50-day SMA: 14.42 Sell
200-day SMA: 15.02 Sell
8-day EMA: 13.91 Buy
20-day EMA: 13.88 Buy
50-day EMA: 14.22 Buy
200-day EMA: 14.65 Sell

JANX Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 48.16 Buy
20-day SMA: 50.4 Buy
50-day SMA: 49.88 Buy
200-day SMA: 44.87 Buy
8-day EMA: 49.16 Buy
20-day EMA: 49.72 Buy
50-day EMA: 49.41 Buy
200-day EMA: 41.75 Buy

Compagnie Financiere Richemont SA Earnings Growth & CFRUY Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.04 per share, and a decrease next year of $0.01 per share.

Janux Therapeutics Earnings Growth & JANX Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.27 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.09 per share, and a decrease next year of $0.91 per share.

Compagnie Financiere Richemont SA Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Janux Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):